number of primer sets required to detect all IMP genes was subsequently found by iterative deduction. The predicted primer sets were tested against 7 IMP-producing bacterial isolates 4, 7, 8, 14, 18, 27 from Serratia, Enterobacteriaceae, Pseudomonas, and Klebsiella spp.) and one synthesized gene of IMP-35. These isolates were chosen to represent the full genetic spectrum of the IMP family. The remaining 40 genes were evaluated based on gene sequences obtained from GenBank.
Results. The in silico analysis showed 6 primer sets were needed to detect all known IMP genes. PCR amplification of template DNA isolated from the 8 strains showed that primer sets 1 and 4 could detect all 8 IMP isolates while the remaining 4 sets (2, 3, 5, 6) had distinct amplification patterns that could be used together to identify a specific IMP gene group. Effectiveness of these primer sets in IMP identification was demonstrated by testing a clinical isolate containing an unidentified carbapenem resistant bacterium. The IMP-27 gene was identified by PCR amplification using the IMP-specific primers designed and confirmed by sequence analysis.
Conclusion. A bioinformatic approach can be used to create an assay for bacterial resistance. The assay developed with this approach can detect and classify all known IMP metallo-β-lactamase genes in carbapenem resistant Gram-negative bacteria. Such information could aid in guiding treatment and evaluating the epidemiology of IMPproducing bacteria.
Disclosures. All authors: No reported disclosures. Background. Tuberculosis (TB) remains a major global public health problem. Recent guidelines recommend screening of high-risk patients for latent TB infection, with the preferential use of interferon gamma release assays (IGRA) over PPD. However, there are several reports of reversions and conversion of quantiferon TB tests (QTF).
Quantiferon conversions and reversions among HIV patients on antiretroviral therapy
Methods. The primary aim of this retrospective review among HIV positive patients, >18 years of age, performed from January 2011 to April 2017, was to measure the occurrence of QTF conversions (negative to positive) and reversions (positive to negative) during routine clinical care. Continuous variables will be presented as mean, standard deviation. Categorical variables will be presented as the number and percentage of subjects in each category.
Results. There were a total of 381 cases, with an average age of 52.8 (±12) years of age. From those 249 patients had at least one QTF performed during the study period and 98 patients had 2 or more tests. 196 had a PPD test performed.
From the patients that were initially QTF negative (N = 100), 7 converted to positive.
There were a total of 10 patients who's QTF was positive and were retested, and from those 7 reversed to negative (see Table 1 ). Most cases that reversed were considered to be low positives (5/6 of those where initial values available).
There were 21 patients had a history of positive PPD and 16 of those had negative QTF.
Conclusion. Reversions were common among HIV positive patients with high CD counts. Most reversions occurred with initial low positive QTF results. Providers should consider confirmatory testing among patients with QTF conversion and no history of TB exposure in low-risk settings. Future studies must be done to confirm these findings. 
